To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the study design of various pharmaceutical ophthalmic clinical trials was completed. Discrepancies as a result of study shortcomings may explain observed differences between reported ophthalmic trial data and observed clinical results

Varner, Paul

English

PubMed

Paul VarnerJohn J Pershing Veterans&amp;rsquo; Administration Medical Center, Poplar Bluff, Missouri, USAAbstract: To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the study design of various pharmaceutical ophthalmic clinical trials was completed. Discrepancies as a result of study shortcomings may explain observed differences between reported ophthalmic trial data and observed clinical results.Keywords: evidence-based medicine, validity, bias, gold standar

Paul Varner

Directory of Open Access Journals

Clinical Ophthalmology

Potential bias in ophthalmic pharmaceutical clinical trials

A decade of directto-consumer advertising of prescription drugs.

All members of primary care team are aware of importance of evidence based medicine.

An ophthalmologist’s guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.

Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Association of funding and conclusions in randomized drug trials.

Atlas of clinical ophthalmology.

Bacterial conjunctivitis.

Bias and causal associations in observational research.

Bibliometric analysis of the literature of randomized controlled trials.

Clinical efﬁ cacy of moxiﬂ oxacin in the treatment of bacterial keratitis. A randomized clinical trial.

Clinical trial design issues: at least 10 things you should look for in clinical trials.

Clinical trial listings by medical area [online].

Coehn GR for the STOP-ROP Multicenter Study Group.

Collaborative Normal-Tension Glaucoma Study Group.

Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity.

Commission to double pharmaceutical research spending but more needs to be done [online].

Comparison of the clinical efﬁ -cacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model. Clin Ther,

Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol,

Cure for dry eye.

Design and analysis of clinical trials: concepts and methodologies. 2nd ed.

Diabetic Retinopathy Study Group.

Do skin prick and conjunctival provocation tests predict symptom severity in seasonal allergic rhinoconjunctivitis? Clin Exp Allergy,

Encyclopedia of biostatistics.

Engaging families in health services research on childhood visual impairment: barriers to, and degree and nature of bias in, participation.

Epidemiology and management of orbital fractures.

European Glaucoma Prevention Study Group.

Evidence-based eye care. Evidence-Based Ophthalmol,

Evidence-based medicine and clinical trials – from a clinical trials unit perspective.

Evidence-based Medicine: How to Practice and Teach Evidence-based Medicine.

Evidence-based medicine: what it is and what it isn’t.

for the Adenomatous Polyp Prevention on Vioxx (APPROVe) trial investigators.

for the CIGTS Study Group.

for the CsA Phase 3 Study Group.

for the Early Manifest Glaucoma Trial Group.

for the FOCUS Study Group.

for the MARINA Study Group.

for the PanAmerican Collaborative Retina Study Group.

for the VEGF Inhibition study in Ocular Neovacularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration.

Handsearching [online].

Heparin use in acute ischaemic stroke: does evidence change practice?

How evidence-based are publications in clinical ophthalmic journals? Invest Ophthalmol Vis Sci,

Impact of unilateral and bilateral vision loss on quality of life.

Interpreting automated perimetry.

New treatments for AMD.

Objective measurement of allergic reactions in the eye. Curr Opin Allergy Clin Immunol,

Ofﬁ ce.

Ophthalmic education: principles and guidelines of a curriculum for ophthalmic education of medical students: chapter 1: preamble [online].

Ophthalmic research and epidemiology: evaluation and application.

Ophthalmology Journals [online].

Pattern visual evoked potentials in the assessment of visual acuity in malingering. Ophthalmol

Pharmaceutical Research and Manufacturers of America.

Photocoagulation Study Group.

Precision of conjunctival provocation tests in right and left eyes.

Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema. Arch Ophthalmol,

President’s Column: Heeding the public’s call for better quality and safety [online].

Prophylactic treatment of Wilson’s disease.

Randomized clinical trials of choroidal melanoma treatment.

Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Ann Fam Med,

Retinopathy Clinical Research Network.

Sample size for a clinical trial: why do some trials need only 100 patients and others 1000 patients or more?

Single-ﬁ eld fundus photography for diabetic retinopathy screening: a report by the American academy of ophthalmology.

Sources of evidence in HIV/ AIDS care: pilot study comparing family physicians and AIDS service organization staff.

Submacular Surgery Trials Pilot Study Investigators.

The “not quite” natural history of normaltension glaucoma.

The Advanced Glaucoma Intervention Study Investigators.

The Age-Related Eye Disease Study Research Group.

The Centers for Disease Control and Prevention.

The EC-IC Bypass Study Group.

The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists.

The ocular hypertension treatment study. A randomized trial determines that topical ocular hypertensive medication delays or prevents the onset of primary openangle glaucoma. Arch Ophthalmol,

The pursuit of excellence.

Top 50 Pharmaceutical Companies Charts and Lists [online].

Topical antibiotics for acute bacterial conjunctivitis: a systematic review.

treatment Diabetic Retinopathy Study Research Group.

Treatment of Age-related Macular Degeneration with Photodynamic Therapy and Verteporﬁ n in Photodynamic Therapy Study Groups.

Treatment of Age-related Macular Degeneration with photodynamic Therapy Study Group.

Updating the cost of a new chemical entity. Ofﬁ ce of Health Economics.

Using clinical evidence.

Using numerical results from systematic reviews in clinical practice.

Verteporﬁ n in Photodynamic Therapy (VIP) Study Group.

What we don’t know about evidence and medical practice: issues raised by Project ImpACT and lessons from the impact literature [online]. The Cochrane Collaboration website.

Working Group. 1993–2000. Users’ guide to the medical literature series. Available via Centre for Health Evidence [online].

World economic outlook database [online].

http://doaj.org/search?source=%7B%22query%22%3A%7B%22bool%22%3A%7B%22must%22%3A%5B%7B%22term%22%3A%7B%22id%22%3A%2212c8bb65eba64033ac521bbd993f403b%22%7D%7D%5D%7D%7D%7D

Potential bias in ophthalmic pharmaceutical clinical trials

Abstract

Similar works

Full text

Available Versions

Directory of Open Access Journals